Sfoglia per Rivista
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
2021-01-01 Heffler, Enrico; Detoraki, Aikaterini; Contoli, Marco; Papi, Alberto; Paoletti, Giovanni; Malipiero, Giacomo; Brussino, Luisa; Crimi, Claudia; Morrone, Daniela; Padovani, Marianna; Guida, Giuseppe; Gerli, Alberto Giovanni; Centanni, Stefano; Senna, Gianenrico; Paggiaro, Pierluigi; Blasi, Francesco; Canonica, Giorgio Walter
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA)
2003-01-01 Bousquet, J; Van Cauwenberge, P; Bachert, C; Canonica, Giorgio; Demoly, P; Durham, Sr; Fokkens, W; Lockey, R; Meltzer, Eo; Mullol, J; Naclerio, Rm; Price, D; Simons, Fe; Vignola, Am; Warner, Jo; European Academy of, Allergy; Clinical, Immunology; Allergic, Rhinitis; its Impact on, Asthma
RhinAsthma Patient Perspective: A short daily asthma and rhinitis QoL assessment
2012-01-01 Braido, F.; Baiardini, I.; Stagi, E.; Scichilone, N.; Rossi, O.; Lombardi, C.; Ridolo, E.; Gani, F.; Balestracci, Sara; Girbino, G.; Senna, G. E.; Bordo, Alberto; Church, M. K.; Canonica, G. W.
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma
2003-01-01 Baiardini, I; Pasquali, M; Giardini, A; Specchia, C; Passalacqua, Giovanni; Venturi, S; Braido, Fulvio; Bonini, S; Majani, G; Canonica, Giorgio
Rhinitis and asthma in athletes: an ARIA document in collaboration with GALEN
2006-01-01 Bonini, S; Bonini, M; Bousquet, J; V., Brusasco; Canonica, Gw; Carlsen, Kh; Corbetta, L; Cummiskey, J; Delgado, L; DEL GIACCO, Sr; Haahtela, T; Jaeger, S; Moretti, C; Palange, P; Passalacqua, G; Passali, D; Pedersen, Bk; Popov, T; Rasi, G; Ventura, Mt; Vignola, Am
Rupatadine in allergic rhinitis and chronic urticaria
2008-01-01 Mullol, J; Bousquet, J; Bachert, C; Canonica, Wg; Gimenez-Arnau, A; Kowalski, Ml; Martí-Guadaño, E; Maurer, M; Picado, C; Scadding, G; Van Cauwenberge, P
Safety of celecoxib in patients with adverse reactions to nimesulide
2005-01-01 Liccardi, G; D'Amato, G; Canonica, Gw; Lobefalo, G; Noschese, P; Piccolo, A; Salzillo, A; Passalacqua, G
Safety of sublingual immunotherapy with a monomeric allergoid in very young children
2005-01-01 F., Agostinis; L., Tellarini; Canonica, G.; P., Falagiani; Passalacqua, G. .
Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study
2001-01-01 Lombardi, C; Gargioni, S; Melchiorre, A; Tiri, A; Falagiani, P; Canonica, Giorgio; Passalacqua, Giovanni
Seasonal and perennial allergic rhinitis: is this classification adherent to real life?
2005-01-01 Ciprandi, G; Cirillo, I; Vizzaccaro, A; Tosca, M; Passalacqua, G; Pallestrini, E; Canonica, Gw
Severe respiratory allergy induced by indirect exposure to rabbit dander: a case report
2004-01-01 Liccardi, G; D'Amato, G; Canonica, Gw; Dente, B; Passalacqua, G
Severe skin reaction due to excipients of an oral iron treatment
2007-01-01 Rogkakou, A; Guerra, L; Scordamaglia, A; Canonica, Gw; Passalacqua, G
Sisters but not twins
2017-01-01 Bagnasco, D; Ferrando, M; Balbi, F; Caminati, M; Varricchi, G; Heffler, E; Puggioni, F; Passalacqua, G; Canonica, G
Sleep disturbances in allergic diseases
2006-01-01 Baiardini, I; Braido, Fulvio; Cauglia, S; Canonica, Giorgio
Specific conjunctival challenge in polysensitized subjects
1997-01-01 Ciprandi, G; Catrullo, A; Ballestrero, A; Cerqueti, P; Tosca, M; Canonica, Gw
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper
2010-01-01 Braido, Fulvio; Bousquet, Pj; Brzoza, Z; Canonica, Giorgio; Compalati, E; Fiocchi, A; Fokkens, W; Gerth van Wijk, R; La Grutta, S; Lombardi, C; Maurer, M; Pinto, Am; Ridolo, E; Senna, Ge; Terreehorst, I; Todo Bom, A; Bousquet, J; Zuberbier, T; Baiardini, I.
Standards for practical allergen-specific immunotherapy
2006-01-01 Alvarez-Cuesta, E; Bousquet, J; Canonica, Gw; Durham, Sr; Malling, Hj; Valovirta, E; EAACI Immunotherapy Task, Force
Statistical advice provided by ChatGPT regarding an accepted article in Allergy
2023-01-01 Ordak, M; Canonica, Gw; Paoletti, G; Brussino, L; Carvalho, D; Di Bona, D
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009
2009-01-01 Canonica, G.; J, Bousquet; T, Casale; Rf, Lockey; Ce, BAENA-CAGNANI; R, Pawankar; Pc, Potter; Pj, Bousquet; Ls, Cox; Sr, Durham; Hs, Nelson; G, Passalacqua; Dp, Ryan; Jl, Brozek; E, Compalati; R, Dahl; L, Delgado; WIJK RG, Van; Rg, Gower; Dk, Ledford; Nr, Filho; Ej, Valovirta; Om, Yusuf; T, Zuberbier; W, Akhanda; Rc, Almarales; I, Ansotegui; F, Bonifazi; J, Ceuppens; T, Chivato; D, Dimova; D, Dumitrascu; L, Fontana; Ch, Katelaris; R, Kaulsay; P, Kuna; D, LARENAS-LINNEMANN; M, Manoussakis; K, Nekam; C, Nunes; R, O'Hehir; Jm, Olaguibel; Nb, Onder; Jw, Park; A, Priftanji; R, Puy; L, Sarmiento; G, Scadding; P, SCHMID-GRENDELMEIER; E, Seberova; R, Sepiashvili; D, Solé; A, Togias; C, Tomino; E, Toskala; H, VAN BEEVER; S, Vieths
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial
2004-01-01 Pajno, Gb; Passalacqua, Giovanni; Canonica, Giorgio; Caminiti, L; Parmiani, S; Barberio, G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? | 1-gen-2021 | Heffler, Enrico; Detoraki, Aikaterini; Contoli, Marco; Papi, Alberto; Paoletti, Giovanni; Malipiero, Giacomo; Brussino, Luisa; Crimi, Claudia; Morrone, Daniela; Padovani, Marianna; Guida, Giuseppe; Gerli, Alberto Giovanni; Centanni, Stefano; Senna, Gianenrico; Paggiaro, Pierluigi; Blasi, Francesco; Canonica, Giorgio Walter | |
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA) | 1-gen-2003 | Bousquet, J; Van Cauwenberge, P; Bachert, C; Canonica, Giorgio; Demoly, P; Durham, Sr; Fokkens, W; Lockey, R; Meltzer, Eo; Mullol, J; Naclerio, Rm; Price, D; Simons, Fe; Vignola, Am; Warner, Jo; European Academy of, Allergy; Clinical, Immunology; Allergic, Rhinitis; its Impact on, Asthma | |
RhinAsthma Patient Perspective: A short daily asthma and rhinitis QoL assessment | 1-gen-2012 | Braido, F.; Baiardini, I.; Stagi, E.; Scichilone, N.; Rossi, O.; Lombardi, C.; Ridolo, E.; Gani, F.; Balestracci, Sara; Girbino, G.; Senna, G. E.; Bordo, Alberto; Church, M. K.; Canonica, G. W. | |
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma | 1-gen-2003 | Baiardini, I; Pasquali, M; Giardini, A; Specchia, C; Passalacqua, Giovanni; Venturi, S; Braido, Fulvio; Bonini, S; Majani, G; Canonica, Giorgio | |
Rhinitis and asthma in athletes: an ARIA document in collaboration with GALEN | 1-gen-2006 | Bonini, S; Bonini, M; Bousquet, J; V., Brusasco; Canonica, Gw; Carlsen, Kh; Corbetta, L; Cummiskey, J; Delgado, L; DEL GIACCO, Sr; Haahtela, T; Jaeger, S; Moretti, C; Palange, P; Passalacqua, G; Passali, D; Pedersen, Bk; Popov, T; Rasi, G; Ventura, Mt; Vignola, Am | |
Rupatadine in allergic rhinitis and chronic urticaria | 1-gen-2008 | Mullol, J; Bousquet, J; Bachert, C; Canonica, Wg; Gimenez-Arnau, A; Kowalski, Ml; Martí-Guadaño, E; Maurer, M; Picado, C; Scadding, G; Van Cauwenberge, P | |
Safety of celecoxib in patients with adverse reactions to nimesulide | 1-gen-2005 | Liccardi, G; D'Amato, G; Canonica, Gw; Lobefalo, G; Noschese, P; Piccolo, A; Salzillo, A; Passalacqua, G | |
Safety of sublingual immunotherapy with a monomeric allergoid in very young children | 1-gen-2005 | F., Agostinis; L., Tellarini; Canonica, G.; P., Falagiani; Passalacqua, G. . | |
Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study | 1-gen-2001 | Lombardi, C; Gargioni, S; Melchiorre, A; Tiri, A; Falagiani, P; Canonica, Giorgio; Passalacqua, Giovanni | |
Seasonal and perennial allergic rhinitis: is this classification adherent to real life? | 1-gen-2005 | Ciprandi, G; Cirillo, I; Vizzaccaro, A; Tosca, M; Passalacqua, G; Pallestrini, E; Canonica, Gw | |
Severe respiratory allergy induced by indirect exposure to rabbit dander: a case report | 1-gen-2004 | Liccardi, G; D'Amato, G; Canonica, Gw; Dente, B; Passalacqua, G | |
Severe skin reaction due to excipients of an oral iron treatment | 1-gen-2007 | Rogkakou, A; Guerra, L; Scordamaglia, A; Canonica, Gw; Passalacqua, G | |
Sisters but not twins | 1-gen-2017 | Bagnasco, D; Ferrando, M; Balbi, F; Caminati, M; Varricchi, G; Heffler, E; Puggioni, F; Passalacqua, G; Canonica, G | |
Sleep disturbances in allergic diseases | 1-gen-2006 | Baiardini, I; Braido, Fulvio; Cauglia, S; Canonica, Giorgio | |
Specific conjunctival challenge in polysensitized subjects | 1-gen-1997 | Ciprandi, G; Catrullo, A; Ballestrero, A; Cerqueti, P; Tosca, M; Canonica, Gw | |
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper | 1-gen-2010 | Braido, Fulvio; Bousquet, Pj; Brzoza, Z; Canonica, Giorgio; Compalati, E; Fiocchi, A; Fokkens, W; Gerth van Wijk, R; La Grutta, S; Lombardi, C; Maurer, M; Pinto, Am; Ridolo, E; Senna, Ge; Terreehorst, I; Todo Bom, A; Bousquet, J; Zuberbier, T; Baiardini, I. | |
Standards for practical allergen-specific immunotherapy | 1-gen-2006 | Alvarez-Cuesta, E; Bousquet, J; Canonica, Gw; Durham, Sr; Malling, Hj; Valovirta, E; EAACI Immunotherapy Task, Force | |
Statistical advice provided by ChatGPT regarding an accepted article in Allergy | 1-gen-2023 | Ordak, M; Canonica, Gw; Paoletti, G; Brussino, L; Carvalho, D; Di Bona, D | |
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009 | 1-gen-2009 | Canonica, G.; J, Bousquet; T, Casale; Rf, Lockey; Ce, BAENA-CAGNANI; R, Pawankar; Pc, Potter; Pj, Bousquet; Ls, Cox; Sr, Durham; Hs, Nelson; G, Passalacqua; Dp, Ryan; Jl, Brozek; E, Compalati; R, Dahl; L, Delgado; WIJK RG, Van; Rg, Gower; Dk, Ledford; Nr, Filho; Ej, Valovirta; Om, Yusuf; T, Zuberbier; W, Akhanda; Rc, Almarales; I, Ansotegui; F, Bonifazi; J, Ceuppens; T, Chivato; D, Dimova; D, Dumitrascu; L, Fontana; Ch, Katelaris; R, Kaulsay; P, Kuna; D, LARENAS-LINNEMANN; M, Manoussakis; K, Nekam; C, Nunes; R, O'Hehir; Jm, Olaguibel; Nb, Onder; Jw, Park; A, Priftanji; R, Puy; L, Sarmiento; G, Scadding; P, SCHMID-GRENDELMEIER; E, Seberova; R, Sepiashvili; D, Solé; A, Togias; C, Tomino; E, Toskala; H, VAN BEEVER; S, Vieths | |
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial | 1-gen-2004 | Pajno, Gb; Passalacqua, Giovanni; Canonica, Giorgio; Caminiti, L; Parmiani, S; Barberio, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile